Nanocarriers as treatment modalities for hypertension

Nanocarriers as treatment modalities for hypertension

Hypertension, a worldwide epidemic at present, is not a disease in itself rather it is an important risk factor for serious cardiovascular disorders including myocardial infarction, stroke, heart failure, and peripheral artery disease. Though numerous drugs acting via different mechanism of action a...

Full description

Bibliographic Details
Main Authors:	Tausif Alam, Saba Khan, Bharti Gaba, Md. Faheem Haider, Sanjula Baboota, Javed Ali
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-01-01
Series:	Drug Delivery
Subjects:	antihypertensive novel molecular targets for hypertension therapy oral drug delivery constraints nanotechnology gene silencing
Online Access:	http://dx.doi.org/10.1080/10717544.2016.1255999

Similar Items

Evaluation of the Medical Care of Patients with Hypertension in an Emergency Department and in Ambulatory Hypertension Unit
by: Fernando Nobre, et al.
Published: (2002-02-01)

Physical training influence on blood pressure dynamics and target organs status in arterial hypertension patients
by: N. I. Gromnatsky, et al.
Published: (1970-01-01)

Management of hypertension in the elderly: Looking for a trade-off between cardiovascular prevention and serious adverse events
by: Agata Buonacera, et al.
Published: (2018-06-01)

The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
by: I Ye Chazova, et al.
Published: (2017-12-01)

The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
by: Chazova I.Ye., et al.
Published: (2017-09-01)

Associations between Hypertension, Treatment, and Cognitive Function in the Irish Longitudinal Study on Ageing
by: Sook Ling Leong, et al.
Published: (2020-11-01)

Up-to-Date Approach to the Treatment of Hypertension
by: Zeki Aydın, et al.
Published: (2014-12-01)

Choice of treatment based on Turkish hypertension consensus report: Do we follow the recommendations?
by: Gülden Yürüyen, et al.
Published: (2018-01-01)

Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson’s Disease Model
by: Bharti Gaba, et al.
Published: (2019-01-01)

Primary orthostatic hypertension: A case report and literature review
by: Yi-Xi Wang, et al.
Published: (2019-01-01)

Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives
by: Inés Serrano-Sevilla, et al.
Published: (2019-07-01)

THE IMPORTANCE OF MEDICATION ADHERENCE ASSESSMENT FOR HYPERTENSIVE PATIENTS
by: Adina Turcu-Stiolica, et al.
Published: (2019-11-01)

What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)

The influence of patients' knowledge of hypertension on the control of their blood pressure: Qualitative study
by: Halgato Tinde I., et al.
Published: (2020-01-01)

Clinical profile and drug therapy of outpatients with arterial hypertension
by: N. V. Izmozherova, et al.
Published: (2020-05-01)

Incidence of hypertension in Taura, Northern Nigeria: Lessons for our health care
by: NCE Okpala, et al.
Published: (2011-01-01)

Evaluation and treatment of hypertensive crises in children
by: Stein DR, et al.
Published: (2016-03-01)

Prevalence of hypertension in the urban population of Catanduva, in the State of São Paulo, Brazil
by: Olavo de Carvalho Freitas, et al.
Published: (2001-07-01)

Analysis of antihypertensive therapy and its adherence in hypertensive patients with and without concomitant diabetes mellitus
by: V A Sergeyeva
Published: (2012-12-01)

Study of chitosan-based nanocarrier for drug delivery.
Published: (2011)

Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment
by: A V Aksenova, et al.
Published: (2018-09-01)

Arterial hypertension and stroke primary prevention
by: O. D. Ostroumova, et al.
Published: (2005-08-01)

What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations
by: Denker MG, et al.
Published: (2013-11-01)

Treatment options for hypertension in high-risk patients
by: Tsai W
Published: (2011-03-01)

ANTIHYPERTENSIVE DRUG THERAPY FOR HYPERTENSIVE DISORDERS IN PREGNANCY
by: Slobodan Jankovic, et al.
Published: (2008-10-01)

Impact of antihypertensive therapy on clinical Status and quality of life in patients with initial manifestations of hypertensive encephalopathy
by: Yuriy Yakovlevich Varakin, et al.
Published: (2010-12-01)

Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
by: Yu. A. Balanova, et al.
Published: (2019-09-01)

Effect of antihypertensive therapy on cognitive functions of patients with hypertension
by: Jaiswal Ashok, et al.
Published: (2010-01-01)

Nanotechnology and Drug Delivery: An Update in Oncology
by: Tait Jones, et al.
Published: (2011-04-01)

ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES
by: S. A. Shalnova, et al.
Published: (2015-12-01)

Clinicoeconomic effectiveness of using psychotherapy to treat patients with essential hypertension
by: Zh A Kalmataeva, et al.
Published: (2015-01-01)

Formula Jamu Antihipertensi and captopril are equally effective in patients with hypertension
by: Atina Hussaana, et al.
Published: (2016-08-01)

Possibilities of antihypertensive therapy in correction of cognitive impairment in hypertensive patients
by: V. A. Skybchyk, et al.
Published: (2020-01-01)

DANGER OF ALCOHOL FOR PATIENTS WITH ARTERIAL HYPERTENSION DURING ANTIHYPERTENSIVE THERAPY
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Observational study on patients’ compliance with Irbesartan in essential hypertension “I Comply”
by: K. Leon, et al.
Published: (2014-03-01)

Management of hypertension in the elderly patient
by: Gordon Stewart Stokes
Published: (2009-09-01)

Calcium antagonist lercanidipine in hypertension
by: G. A Baryshnikova, et al.
Published: (2014-03-01)

USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES
by: V. R. Abdrakhmanov, et al.
Published: (2015-09-01)

Fixed dosed combinations in the treatment of hypertension
by: Gabriel Hancu, et al.
Published: (2020-03-01)

The effects of arterial hypertension on aortic valve stenosis
by: Ivanović Branislava, et al.
Published: (2010-01-01)